Regulation_NN
of_IN
interleukin-1_NN
beta_NN
production_NN
by_IN
glucocorticoids_NNS
in_IN
human_JJ
monocytes_NNS
:_:
the_DT
mechanism_NN
of_IN
action_NN
depends_VBZ
on_IN
the_DT
activation_NN
signal_NN
._.

Glucocorticoids_NNS
are_VBP
known_VBN
to_TO
downregulate_VB
interleukin-1_NN
beta_NN
production_NN
in_IN
monocytic_JJ
cells_NNS
by_IN
two_CD
different_JJ
mechanims_NNS
:_:
direct_JJ
inhibition_NN
of_IN
the_DT
gene_NN
transcription_NN
and_CC
destabilization_NN
of_IN
the_DT
preformed_JJ
interleukin-1_NN
beta_NN
mRNA_NN
._.

Now_RB
we_PRP
have_VBP
examined_VBN
the_DT
effect_NN
of_IN
the_DT
nature_NN
of_IN
the_DT
monocyte_NN
activating_VBG
signal_NN
on_IN
these_DT
two_CD
inhibitory_JJ
mechanims_NNS
._.

When_WRB
human_JJ
monocytes_NNS
were_VBD
preincubated_VBN
with_IN
dexamethasone_NN
for_IN
1_CD
hour_NN
and_CC
then_RB
stimulated_VBN
either_CC
with_IN
bacterial_JJ
lipopolysaccharide_NN
or_CC
phorbol_NN
myristate_NN
,_,
it_PRP
was_VBD
found_VBN
that_IN
dexamethasone_NN
inhibited_VBD
the_DT
lipopolysaccharide-induced_JJ
interleukin-1_NN
beta_NN
protein_NN
production_NN
,_,
but_CC
the_DT
phorbol_NN
myristate-induced_JJ
production_NN
was_VBD
increased_VBN
3-10_CD
fold_RB
._.

This_DT
difference_NN
was_VBD
also_RB
seen_VBN
at_IN
the_DT
mRNA_NN
level_NN
._.

When_WRB
dexamethasone_NN
was_VBD
added_VBN
to_TO
the_DT
cultures_NNS
3_CD
hours_NNS
after_IN
the_DT
stimulators_NNS
,_,
it_PRP
clearly_RB
decreased_VBD
the_DT
interleukin-1_NN
beta_NN
mRNA_NN
levels_NNS
regardless_RB
of_IN
the_DT
stimulator_NN
used_VBN
-LRB-_-LRB-
although_IN
the_DT
effect_NN
was_VBD
clearly_RB
weaker_JJR
on_IN
the_DT
PMA-induced_JJ
mRNA_NN
-RRB-_-RRB-
._.

Thus_RB
these_DT
data_NNS
suggest_VBP
that_IN
the_DT
phorbol_NN
myristate-induced_JJ
signal_NN
-LRB-_-LRB-
prolonged_JJ
protein_NN
kinase_NN
C_NN
activation_NN
?_.
-RRB-_-RRB-
can_MD
not_RB
be_VB
inhibited_VBN
by_IN
prior_JJ
incubation_NN
with_IN
dexamethasone_NN
and_CC
it_PRP
also_RB
protects_VBZ
the_DT
induced_JJ
mRNA_NN
for_IN
the_DT
degradative_JJ
action_NN
of_IN
dexamethasone_NN
._.

